newsfilter
← Latest News
ACCESS Newswire·

Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting

Initial Phase 1/2 data highlight the potential of Moderna's multiplexed mRNA approach in relapsed or refractory multiple myeloma CAMBRIDGE, MA / ACCESS Newswire / November 4, 2026 / Moderna, Inc.